Aprile M, Cataldi S, Perfetto C, Federico A, et al. Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1alpha-mediated glycolytic phenotype. Br J Cancer 2023 May 17. doi: 10.1038/s41416-023-02282.
PMID: 37198319